Linfomas
GLUN
French Institute of Health and Medical Research
París, FranciaPublications en collaboration avec des chercheurs de French Institute of Health and Medical Research (2)
2022
-
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, Núm. 7, pp. 483-494